NCT04233229 - Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes Patients (T2D) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions

Diabetes Type 2

Interventions

DEVICE

t:slim X2 with Control-IQ

closed-loop in patients at home for three months

OTHER

home healthcare services

home healthcare services from Air Liquide in patients at home for three months

OTHER

usual care for daily insulin treatment

multiple daily injection insulin regimen with family nurse's daily assistance at home for performing insulin injections and/or glucose monitoring

Trial Locations (10)

13003

Hopital Européen de Marseille, Marseille

14033

CHU Caen, Caen

29609

CHRU Brest, Brest

31059

CHU Toulouse, Toulouse

44093

CHU Nantes, Nantes

54511

CHRU Nancy-Hôpitaux de Brabois, Vandœuvre-lès-Nancy

67091

CHU Strasbourg, Strasbourg

75475

APHP Lariboisière, Paris

76230

CHU Rouen, Rouen

80054

CHU Amiens, Amiens

All Listed Sponsors

collaborator

International Clinical Trials Association

OTHER

lead

Air Liquide Santé International

INDUSTRY